• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZIMMER/BIOMET GEL-ONE INJ 30MG/3ML; ACID HYALURONIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZIMMER/BIOMET GEL-ONE INJ 30MG/3ML; ACID HYALURONIC Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problems Pain (1994); Limited Mobility Of The Implanted Joint (2671)
Event Date 01/25/2018
Event Type  Injury  
Event Description
Pt 2 weeks out from injections and reported decreased in function in knees.Still having pain and feels like knees have hardened.Advised no refund available for therapy issue.Discussed expectations from therapy and possible treatment failure may have occurred.Directed mbr back to dr and possible alternative to gel-one may be needed.Rph.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GEL-ONE INJ 30MG/3ML
Type of Device
ACID HYALURONIC
Manufacturer (Section D)
ZIMMER/BIOMET
MDR Report Key7244559
MDR Text Key99246130
Report NumberMW5075079
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 01/25/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/05/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? No Information
Type of Device Usage N
Patient Sequence Number1
Patient Age52 YR
-
-